Citizen Petition from Siri & Glimstad LLP on behalf of Informed Consent Action Network

The Informed Consent Action Network supports the request for a precautionary principle warning regarding acetaminophen use during pregnancy and labor. They provide a book as a comprehensive index of scientific literature to help the FDA identify and contextualize evidence regarding acetaminophen's potential neurodevelopmental risks.

The Protecting Access to Pain Relief (PAPR) Coalition, a group of 16 national public health organizations, opposes the proposed labeling changes for over-the-counter acetaminophen. They argue that the proposed warnings are not grounded in robust evidence and could restrict access to a vital medication for vulnerable populations who cannot safely take NSAIDs.

The Informed Consent Action Network, represented by Siri & Glimstad LLP, opposes the proposed warning on acetaminophen products. They argue that the action is an unsubstantiated regulatory overreach that could cause economic harm and increase health risks by discouraging the use of a safe fever-reducing medication during pregnancy.

A private individual is requesting that the government adopt a warning on all Tylenol products regarding their use during pregnancy. The commenter argues that pregnant women need full information to make informed decisions about their health and the health of their children.

An individual is requesting that safety labels on all acetaminophen-containing products be updated to warn pregnant women of potential adverse reactions. They argue that informed consent is essential and express support for Robert Kennedy Jr.'s efforts to inform the public about available substances.

The commenter is urging the FDA to mandate a warning label on Tylenol regarding potential neurodevelopmental risks like autism and ADHD during pregnancy. They argue that protecting newborns is a critical priority and that the FDA should not yield to the influence of pharmaceutical companies.